AMYLIN CORP has a total of 36 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Japan, Canada and Finland. Its main competitors in its focus markets pharmaceuticals, biotechnology and semiconductors are BROOKS PETER C, STEALTH PEPTIDES INT INC and STEALTH BIOTHERAPEUTICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | Canada | 4 | |
#3 | Finland | 4 | |
#4 | Norway | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 3 | |
#7 | Denmark | 3 | |
#8 | Ireland | 2 | |
#9 | Mexico | 2 | |
#10 | New Zealand | 2 | |
#11 | EPO (European Patent Office) | 1 | |
#12 | United States | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Semiconductors | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Semiconductor devices | |
#5 | Unspecified technologies | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Cooper Garth James Smith | 16 |
#2 | Cooper Garth J S | 12 |
#3 | Greene Howard E | 9 |
#4 | Leighton Brendan | 5 |
#5 | Willis Anthony Charles | 4 |
#6 | Moore Candace Xavierie | 3 |
#7 | Macintyre Iain | 2 |
#8 | Leighthon Brendan | 2 |
#9 | Moore Candace X | 1 |
#10 | Gaasu Jieimusu Sumisu Kuupaa | 1 |
Publication | Filing date | Title |
---|---|---|
FI950530A | Method for preparing amylin antagonists | |
CA2067738A1 | Hypoglycemics | |
WO9100710A1 | Treatment of bone disorders | |
NZ227601A | Amylin antagonists and method of treatment of type-2 diabetes mellitus; method of screening for or assaying amylin antagonists | |
AU2949489A | Treatment of type 2 diabetes mellitus | |
DK473888D0 | Peptid, procedures for preparing thereof and medicinal product containing peptid | |
CA1341333C | Amylin peptides and uses thereof |